AS
Anmol Saxena
About Anmol Saxena
Data last updated:
Anmol Saxena is a Director at Axton Asia Drugs Private Limited (since 2025) and Director at Ambrion Sterling Dominion Labs India Private Limited (since 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Axton Asia Drugs Private Limited U21001DL2025PTC460712 | Director | 29 Dec 2025 | 2025 | Active | |
| Ambrion Sterling Dominion Labs India Private Limited U21000DL2025PTC459723 | Director | 16 Dec 2025 | 2025 | Active |
Board colleagues of Anmol Saxena
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sapna Srivastwa | 07500565 | Axton Asia Drugs Private Limited , Ambrion Sterling Dominion Labs India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anmol Saxena
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anmol Saxena
Anmol Saxena currently holds 2 directorships: Axton Asia Drugs Private Limited (Director, since 29 Dec 2025); Ambrion Sterling Dominion Labs India Private Limited (Director, since 16 Dec 2025).
Anmol Saxena was first appointed on 16 Dec 2025 as Director at Ambrion Sterling Dominion Labs India Private Limited.
The current boards of Anmol Saxena's companies include Sapna Srivastwa (Axton Asia Drugs Private Limited).